341 related articles for article (PubMed ID: 19916793)
1. The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration.
Leelawat S; Leelawat K; Narong S; Matangkasombut O
Cancer Invest; 2010 May; 28(4):357-63. PubMed ID: 19916793
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
Kim JH; Liu L; Lee SO; Kim YT; You KR; Kim DG
Cancer Res; 2005 Jul; 65(14):6312-20. PubMed ID: 16024633
[TBL] [Abstract][Full Text] [Related]
3. Modulatory role of garlicin in migration and invasion of intrahepatic cholangiocarcinoma via PI3K/AKT pathway.
Xie K; Nian J; Zhu X; Geng X; Liu F
Int J Clin Exp Pathol; 2015; 8(11):14028-33. PubMed ID: 26823715
[TBL] [Abstract][Full Text] [Related]
4. Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.
Preet A; Ganju RK; Groopman JE
Oncogene; 2008 Jan; 27(3):339-46. PubMed ID: 17621270
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
6. Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.
Jia W; Hegde VL; Singh NP; Sisco D; Grant S; Nagarkatti M; Nagarkatti PS
Mol Cancer Res; 2006 Aug; 4(8):549-62. PubMed ID: 16908594
[TBL] [Abstract][Full Text] [Related]
7. Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells.
Ishimura N; Isomoto H; Bronk SF; Gores GJ
Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G129-36. PubMed ID: 16166346
[TBL] [Abstract][Full Text] [Related]
8. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway.
Techasen A; Loilome W; Namwat N; Takahashi E; Sugihara E; Puapairoj A; Miwa M; Saya H; Yongvanit P
Cancer Sci; 2010 Mar; 101(3):658-65. PubMed ID: 20047593
[TBL] [Abstract][Full Text] [Related]
9. Expression and antitumor effects of TRAIL in human cholangiocarcinoma.
Tanaka S; Sugimachi K; Shirabe K; Shimada M; Wands JR
Hepatology; 2000 Sep; 32(3):523-7. PubMed ID: 10960444
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.
Xiong GP; Zhang JX; Gu SP; Wu YB; Liu JF
Neoplasma; 2012; 59(4):409-15. PubMed ID: 22489696
[TBL] [Abstract][Full Text] [Related]
11. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C
Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481
[TBL] [Abstract][Full Text] [Related]
12. An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma.
Marzioni M; Torrice A; Saccomanno S; Rychlicki C; Agostinelli L; Pierantonelli I; Rhönnstad P; Trozzi L; Apelqvist T; Gentile R; Candelaresi C; Fava G; Semeraro R; Benedetti A; Gaudio E; Franchitto A; Onori P; De Minicis S; Carpino G; Kallin E; Alvaro D; Nilsson S
Dig Liver Dis; 2012 Feb; 44(2):134-42. PubMed ID: 21782536
[TBL] [Abstract][Full Text] [Related]
13. Effects of CAY10404 on the PKB/Akt and MAPK pathway and apoptosis in non-small cell lung cancer cells.
Cho Y; Park MJ; Park M; Min SS; Yee J; Kim C; Han MS; Han SH
Respirology; 2009 Aug; 14(6):850-8. PubMed ID: 19703066
[TBL] [Abstract][Full Text] [Related]
14. Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB.
Seubwai W; Vaeteewoottacharn K; Hiyoshi M; Suzu S; Puapairoj A; Wongkham C; Okada S; Wongkham S
Cancer Sci; 2010 Jul; 101(7):1590-5. PubMed ID: 20412118
[TBL] [Abstract][Full Text] [Related]
15. Suppression of galectin-3 expression enhances apoptosis and chemosensitivity in liver fluke-associated cholangiocarcinoma.
Wongkham S; Junking M; Wongkham C; Sripa B; Chur-In S; Araki N
Cancer Sci; 2009 Nov; 100(11):2077-84. PubMed ID: 19723119
[TBL] [Abstract][Full Text] [Related]
16. Akt expression may predict favorable prognosis in cholangiocarcinoma.
Javle MM; Yu J; Khoury T; Chadha KS; Iyer RV; Foster J; Kuvshinoff BW; Gibbs JF; Geradts J; Black JD; Brattain MG
J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
[TBL] [Abstract][Full Text] [Related]
17. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target.
Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S
Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475
[TBL] [Abstract][Full Text] [Related]
18. Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma.
Song F; Hu B; Cheng JW; Sun YF; Zhou KQ; Wang PX; Guo W; Zhou J; Fan J; Chen Z; Yang XR
Cell Death Dis; 2020 Jul; 11(7):573. PubMed ID: 32709873
[TBL] [Abstract][Full Text] [Related]
19. Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma.
Chen RF; Li ZH; Zou SQ; Chen JS
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):71-4. PubMed ID: 15730924
[TBL] [Abstract][Full Text] [Related]
20. High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells.
Widmer M; Hanemann CO; Zajicek J
J Neurosci Res; 2008 Nov; 86(14):3212-20. PubMed ID: 18615640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
